FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2589429206> ?p ?o ?g. }

• W2589429206 abstract "Abstract We have previously shown that break-through bleeding in children with severe hemophilia A on prophylaxis is associated with time/week with FVIII less than 1IU/dL (P&lt;0.0001) (Collins et al. JTH. 2008;O-T-018). In clinical practice many clinicians use the trough FVIII to monitor prophylaxis. These parameters depend on dose and frequency of infused FVIII and the patient’s FVIII recovery and elimination half-life (t½). To help guide prescription of prophylactic regimens in clinical practice we aimed to establish the relative importance of these variables on FVIII levels using results from 48 patients aged 1–6 yrs who had undergone a 48h, 50IU/kg pharmacokinetic (PK) study with Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method (Advate). The median (5–95 percentile) recovery was 1.8 (1.4–2.8) IU/dL/IU/kg and t½ 9.4 (7.4–13.1) h. A standard prophylactic regimen (30IU/kg on alternate days) in an average patient (recovery 1.8, t ½ 9.4h) was considered baseline. Each variable was individually adjusted within the observed normal range or clinical practice whilst holding the other variables constant and the effect on trough level and time/week FVIII &lt;1IU/dL was calculated (table). Variable Trough (IU/dL) Time/wk &lt;1IU/dL (h) t½ (hrs) 7.4 &lt;1 17.5 9.4 1.6* 0* 13.1 4.4 0 Recovery 1.4 1.2 0 1.8 1.6* 0* (IU/dL)/(IU/kg) Dose (IU/kg) 2.8 2.5 0 20 1.1 0 30 1.6* 0* 50 2.7 0 Frequency (days) Daily (15 IU/kg) 4.8 0 Alternate day (30 IU/kg) 1.6* 0* Every 3rdday (45 &lt;1 27.8 The in silico modelling showed that the standard regimen in the average patient resulted in a trough level of 1.6IU/dL and no time per week with FVIII &lt;1 (* in table). In contrast, the commonly used regimen of 30IU/kg on Mon/Wed/Fri in the same patient would result in FVIII &lt;1IU/dL for 17.4h on Sunday. The Friday dose would have to be increased to 108.5IU/kg to maintain a trough level above 1IU/dL. Dosing frequency and t½ both had large effects on trough FVIII level and time/week &lt;1IU/dL. Recovery and dose had no effect on time/week with FVIII &lt;1IU/dL and a relatively small effect on trough level. Patients on a standard regimen (30IU/kg alternate day), who have a recovery and t½ on the 5th percentile (1.4IU/dL/IU/kg and 7.4h, respectively), would have a trough level &lt;1IU/dL for approximately 29h per week. In contrast, a patient at the 95th percentile for these parameters (2.8 IU/dL/IU/kg and 13.1h, respectively), would have a trough level of approximately 7IU/dL, spending no time below 1IU/dL. After a 30IU/kg infusion, variation in t½ from 5th to 95th percentile results in a 33h difference from 43 to 76h in time until FVIII falls below 1IU/dL. A similar variation in recovery leads to a 10h difference from 50 to 60h. Increasing the infused dose from 20–50IU/kg in the average patient results in an increase in time until FVIII falls below 1IU/dL of 12h from 50 to 62h. These data confirm that tailoring prophylaxis to bleeding patterns may be enhanced by knowledge of individual patients’ PK. The use of standard 48h PK studies are not practical in clinical practice but techniques are available to estimate individual PK from sparse data that can be obtained in clinical practice. A population PK model under development is one method that will allow individual patient’s PK to be calculated from 3–4 sample points and facilitate the measurement of PK in routine clinical practice. An algorithm based on PK and desired FVIII levels can be used to calculate individualised dosing schedules for patients. In conclusion, to maintain FVIII at a pre-determined level, the frequency of infusion and half life have a more pronounced affect than dose and recovery." @default.
• W2589429206 created "2017-03-03" @default.
• W2589429206 creator A5000491176 @default.
• W2589429206 creator A5009519321 @default.
• W2589429206 creator A5037393708 @default.
• W2589429206 creator A5048779515 @default.
• W2589429206 creator A5064943069 @default.
• W2589429206 creator A5065311756 @default.
• W2589429206 creator A5073976413 @default.
• W2589429206 creator A5083938702 @default.
• W2589429206 creator A5085529896 @default.
• W2589429206 creator A5086748531 @default.
• W2589429206 date "2008-11-16" @default.
• W2589429206 modified "2023-09-28" @default.
• W2589429206 title "Effect of Normal Variation in Factor VIII Pharmacokinetics on Prophylactic Dosing Requirements in Severe Classical Hemophilia." @default.
• W2589429206 doi "https://doi.org/10.1182/blood.v112.11.1222.1222" @default.
• W2589429206 hasPublicationYear "2008" @default.
• W2589429206 type Work @default.
• W2589429206 sameAs 2589429206 @default.
• W2589429206 citedByCount "2" @default.
• W2589429206 countsByYear W25894292062013 @default.
• W2589429206 crossrefType "journal-article" @default.
• W2589429206 hasAuthorship W2589429206A5000491176 @default.
• W2589429206 hasAuthorship W2589429206A5009519321 @default.
• W2589429206 hasAuthorship W2589429206A5037393708 @default.
• W2589429206 hasAuthorship W2589429206A5048779515 @default.
• W2589429206 hasAuthorship W2589429206A5064943069 @default.
• W2589429206 hasAuthorship W2589429206A5065311756 @default.
• W2589429206 hasAuthorship W2589429206A5073976413 @default.
• W2589429206 hasAuthorship W2589429206A5083938702 @default.
• W2589429206 hasAuthorship W2589429206A5085529896 @default.
• W2589429206 hasAuthorship W2589429206A5086748531 @default.
• W2589429206 hasConcept C105795698 @default.
• W2589429206 hasConcept C112705442 @default.
• W2589429206 hasConcept C122048520 @default.
• W2589429206 hasConcept C126322002 @default.
• W2589429206 hasConcept C126894567 @default.
• W2589429206 hasConcept C2777288759 @default.
• W2589429206 hasConcept C2781413609 @default.
• W2589429206 hasConcept C2908647359 @default.
• W2589429206 hasConcept C2909675724 @default.
• W2589429206 hasConcept C2910800852 @default.
• W2589429206 hasConcept C2911091166 @default.
• W2589429206 hasConcept C31785415 @default.
• W2589429206 hasConcept C33923547 @default.
• W2589429206 hasConcept C71924100 @default.
• W2589429206 hasConcept C89838059 @default.
• W2589429206 hasConcept C99454951 @default.
• W2589429206 hasConceptScore W2589429206C105795698 @default.
• W2589429206 hasConceptScore W2589429206C112705442 @default.
• W2589429206 hasConceptScore W2589429206C122048520 @default.
• W2589429206 hasConceptScore W2589429206C126322002 @default.
• W2589429206 hasConceptScore W2589429206C126894567 @default.
• W2589429206 hasConceptScore W2589429206C2777288759 @default.
• W2589429206 hasConceptScore W2589429206C2781413609 @default.
• W2589429206 hasConceptScore W2589429206C2908647359 @default.
• W2589429206 hasConceptScore W2589429206C2909675724 @default.
• W2589429206 hasConceptScore W2589429206C2910800852 @default.
• W2589429206 hasConceptScore W2589429206C2911091166 @default.
• W2589429206 hasConceptScore W2589429206C31785415 @default.
• W2589429206 hasConceptScore W2589429206C33923547 @default.
• W2589429206 hasConceptScore W2589429206C71924100 @default.
• W2589429206 hasConceptScore W2589429206C89838059 @default.
• W2589429206 hasConceptScore W2589429206C99454951 @default.
• W2589429206 hasLocation W25894292061 @default.
• W2589429206 hasOpenAccess W2589429206 @default.
• W2589429206 hasPrimaryLocation W25894292061 @default.
• W2589429206 hasRelatedWork W1572806918 @default.
• W2589429206 hasRelatedWork W1766134840 @default.
• W2589429206 hasRelatedWork W2013687686 @default.
• W2589429206 hasRelatedWork W2020338307 @default.
• W2589429206 hasRelatedWork W2048732547 @default.
• W2589429206 hasRelatedWork W2054017948 @default.
• W2589429206 hasRelatedWork W2064718783 @default.
• W2589429206 hasRelatedWork W2078887465 @default.
• W2589429206 hasRelatedWork W2143635800 @default.
• W2589429206 hasRelatedWork W2154209632 @default.
• W2589429206 hasRelatedWork W2370096648 @default.
• W2589429206 hasRelatedWork W2564322603 @default.
• W2589429206 hasRelatedWork W2582378518 @default.
• W2589429206 hasRelatedWork W2810881824 @default.
• W2589429206 hasRelatedWork W2943590175 @default.
• W2589429206 hasRelatedWork W2949365580 @default.
• W2589429206 hasRelatedWork W2979404524 @default.
• W2589429206 hasRelatedWork W2979874030 @default.
• W2589429206 hasRelatedWork W3128792495 @default.
• W2589429206 hasRelatedWork W2560711935 @default.
• W2589429206 isParatext "false" @default.
• W2589429206 isRetracted "false" @default.
• W2589429206 magId "2589429206" @default.
• W2589429206 workType "article" @default.